Half-year report · Q2
4326.TEDINET S100V6VT
Period2024-07-01 → 2024-12-31
Filed2025-02-06
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥32.0bn | 2024-07-01 → 2024-12-31 | Cons. | Net sales |
| Revenue | ¥63.3bn | 2023-07-01 → 2024-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥30.7bn | 2023-07-01 → 2023-12-31 | Cons. | Net sales |
| Operating income | ¥1.8bn | 2024-07-01 → 2024-12-31 | Cons. | Operating income |
| Operating income | ¥1.5bn | 2023-07-01 → 2023-12-31 | Cons. | Operating income |
| Ordinary income | ¥1.7bn | 2024-07-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.5bn | 2023-07-01 → 2024-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.6bn | 2023-07-01 → 2023-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥3.1bn | 2024-07-01 → 2024-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.6bn | 2023-07-01 → 2023-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.0bn | 2024-07-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.5bn | 2023-07-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.0bn | 2023-07-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥2.0bn | 2024-07-01 → 2024-12-31 | Cons. | Profit loss |
| Net income | ¥1.0bn | 2023-07-01 → 2023-12-31 | Cons. | Profit loss |
| Total assets | ¥45.7bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥45.3bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥45.7bn | at 2023-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥13.2bn | at 2024-12-31 | Cons. | Liabilities |
| Total liabilities | ¥12.9bn | at 2024-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥32.5bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥32.4bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥30.7bn | at 2023-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥11.2bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥12.0bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥12.0bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.9bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.0bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.5bn | at 2023-06-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥483m | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.0bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.6bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥1.4bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥705m | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥300m | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.8bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.2bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥139m | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥52.88 | 2024-07-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥64.47 | 2023-07-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥26.65 | 2023-07-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 70.7% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.1% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.7% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E05239-000Business Intelligencereportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥3.7bn |
| jpcrp040300-q2r_E05239-000Business Intelligencereportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥3.7bn |
| jpcrp040300-q2r_E05239-000Business Intelligencereportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥368m |
| jpcrp040300-q2r_E05239-000Marketing Support Consumer Goods And Servicesreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥21.7bn |
| jpcrp040300-q2r_E05239-000Marketing Support Consumer Goods And Servicesreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥21.7bn |
| jpcrp040300-q2r_E05239-000Marketing Support Consumer Goods And Servicesreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥227m |
| jpcrp040300-q2r_E05239-000Marketing Support Healthcarereportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥6.6bn |
| jpcrp040300-q2r_E05239-000Marketing Support Healthcarereportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥6.6bn |
| jpcrp040300-q2r_E05239-000Marketing Support Healthcarereportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥1.2bn |
| jpcrp040300-q2r_E05239-000Business Intelligencereportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥4.0bn |
| jpcrp040300-q2r_E05239-000Business Intelligencereportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥4.0bn |
| jpcrp040300-q2r_E05239-000Business Intelligencereportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥356m |
| jpcrp040300-q2r_E05239-000Marketing Support Consumer Goods And Servicesreportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥19.2bn |
| jpcrp040300-q2r_E05239-000Marketing Support Consumer Goods And Servicesreportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥19.2bn |
| jpcrp040300-q2r_E05239-000Marketing Support Consumer Goods And Servicesreportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥76m |
| jpcrp040300-q2r_E05239-000Marketing Support Healthcarereportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥7.5bn |
| jpcrp040300-q2r_E05239-000Marketing Support Healthcarereportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥7.5bn |
| jpcrp040300-q2r_E05239-000Marketing Support Healthcarereportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥1.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 522
| Item | Context | Value | Unit |
|---|---|---|---|
| Type1 semi annual consolidated financial statements financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated statement of cash flows (text) | CurrentYTDDuration | Text · Plus | |
| Notes changes in scope of consolidation or equity method (text) | CurrentYTDDuration | Text · Plus | |
| Notes accounting treatments specific to quarterly financial statements quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Debtors notes regarding overdraft contracts and or loan commitments (text) | CurrentQuarterInstant | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYTDDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | CurrentYTDDuration | Text · Plus | |
| Notes business combinations quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |